>
U.S. Strengths and Weaknesses in Production
Washington Lost the Equivalent of Two Apples. Did Anyone Notice?
The Light at The End of the Tunnel - It's Not All Doom & Gloom
Iran has published a naive letter to the American People
A laser just photographed objects through six feet of concrete
Elon Musk's Next-Gen Motor Destroy Entire EV Industry
China's disputed satellite refueling heralds new space war era
BYD Will Put Solid-State Batteries In An EV Next Year: Executive
FDA-cleared exoskeleton puts spinal-cord patients back on their feet
Your Robotic Vacuum Is Watching You -- Could It Someday Testify Against You in Court?
Why Unigrid's Sodium-Ion Batteries Are the Game-Changer for Off-Grid Energy Storage
This Battery On Wheels Makes Any Diesel Truck Electric In 5 Minutes
Mass-Production of AI Infrastructure – Speed Up by 10X
3D-printed Martian mud homes look critical for life beyond Earth

The ability to engineer particles that can enter a human body and transport a drug directly to a targeted cell is revolutionizing how medicine is delivered. A team of researchers from the University of Illinois has now created a new nanoparticle therapy that can target and destroy cancer stem cells to stop the disease returning.
The fear of relapse is one that constantly haunts cancer patients after any initial treatment has moved the disease into remission, but understanding how and why cancer returns eluded scientists for many years. In the mid-1990s, researcher John Dick first identified cancer stem cells, upending the field of cancer research and pointing to an entirely new area of study for scientists.
The discovery was that some cancers can be generated by these cancer stem cells (CSCs), and many existing treatments, while effective in destroying fast-growing cancer cells, completely miss these CSCs.